Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702
What this trial is testing

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

Who this might be right for
MTAP-deleted Solid Tumors
Servier Bio-Innovation LLC 60
Early research (Phase 1)Study completedNCT02301130
What this trial is testing

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Kyowa Kirin, Inc. 64
Early research (Phase 1)Study completedNCT04095273
What this trial is testing

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Who this might be right for
Advanced Solid Tumors
Bayer 56
Testing effectiveness (Phase 2)Study completedNCT01397929
What this trial is testing

An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors

Who this might be right for
Solid Organ Tumors
Basilea Pharmaceutica 73
Early research (Phase 1)Active Not RecruitingNCT04446351
What this trial is testing

Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 107
Early research (Phase 1)Study completedNCT01923337
What this trial is testing

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+5 more
University of California, Davis 17
Early research (Phase 1)Study completedNCT00004881
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT04423029
What this trial is testing

DF6002 Alone and in Combination With Nivolumab

Who this might be right for
Solid Tumors
Dragonfly Therapeutics 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05438329
What this trial is testing

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 1,123
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Early research (Phase 1)Study completedNCT01992341
What this trial is testing

AMG 386 Drug-Drug Interaction Study With Paclitaxel

Who this might be right for
Advanced Solid Tumors
Amgen 35
Early research (Phase 1)Study completedNCT02688101
What this trial is testing

Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Collaborative Medicinal Development Pty Limited 14
Early research (Phase 1)Looking for participantsNCT07470853
What this trial is testing

MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Who this might be right for
PROCPlatinum Resistant Ovarian CancerEndometrial Cancer
Whitehawk Therapeutics, Inc. 265
Early research (Phase 1)Study completedNCT00714181
What this trial is testing

Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Abramson Cancer Center at Penn Medicine 38
Early research (Phase 1)Study completedNCT00003330
What this trial is testing

Interleukin-12 in Treating Patients With Advanced Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Early research (Phase 1)Study completedNCT05508100
What this trial is testing

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Who this might be right for
Advanced Solid Tumor
Immune-Onc Therapeutics 38
Not applicableLooking for participantsNCT06717022
What this trial is testing

A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors

Who this might be right for
Mesothelin Positive Tumors
Tianjin Medical University Cancer Institute and Hospital 24
Early research (Phase 1)Looking for participantsNCT07413328
What this trial is testing

HWS116 Monotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company 56
Early research (Phase 1)Study completedNCT00858377
What this trial is testing

First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+2 more
Amgen 95
Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Next Page